about
Approved Antiviral Drugs over the Past 50 Years(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agentLatent infections of sensory ganglia as influenced by phosphonoformate treatment of herpes simplex virus-induced skin infections in hairless miceRelative potencies of different anti-herpes agents in the topical treatment of cutaneous herpes simplex virus infection of athymic nude miceAntiherpes effects and pharmacokinetic properties of 9-(4-hydroxybutyl) guanine and the (R) and (S) enantiomers of 9-(3,4-dihydroxybutyl)guanineInhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture9-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplicationSynergistic inhibition of human immunodeficiency virus isolates (including 3'-azido-3'-deoxythymidine-resistant isolates) by foscarnet in combination with 2',3'-dideoxyinosine or 2',3'-dideoxycytidineHelicase-primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infections.Inhibition of adenylyl and guanylyl cyclase isoforms by the antiviral drug foscarnet.Structural and functional relationships between prokaryotic and eukaryotic DNA polymerases.Antiviral susceptibility testing with a cell line which expresses beta-galactosidase after infection with herpes simplex virus.Age-related differences in pharmacokinetics of phosphonoformate in cats.Increased efficacy of phosphonoformate and phosphonoacetate inhibition of herpes simplex virus type 2 replication by encapsulation in liposomes.Structure-activity studies on phosphonoacetate.Susceptibility of vaccine strains of varicella-zoster virus to antiviral compoundsInflammatory cells in transplanted kidneys are infected by human cytomegalovirus.Antiviral therapy: current concepts and practicesDNA and RNA virus species are inhibited by xanthates, a class of antiviral compounds with unique propertiesThe ULb' region of the human cytomegalovirus genome confers an increased requirement for the viral protein kinase UL97.Posttranscriptional regulation of a class of human cytomegalovirus phosphoproteins encoded by an early transcription unit.Identification and characterization of a major early cytomegalovirus DNA-binding protein.Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locusD,L-alpha-difluoromethylornithine inhibits human cytomegalovirus replicationAntiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): DNA viruses.Phosphonoformate inhibition of visna virus replication.Concentration-dependent effects of foscarnet on the cell cycle.Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): retroviruses and hepadnaviruses.Multicomponent origin of cytomegalovirus lytic-phase DNA replication.Boundaries and structure of human cytomegalovirus oriLyt, a complex origin for lytic-phase DNA replication.Specific targets for antiviral drugs.Reversible effects on cellular metabolism and proliferation by trisodium phosphonoformate.Characteristics of herpesvirus mutants resistant to phosphonoformate and phosphonoacetate.A precise termination site in the mouse beta-major globin transcription unit.Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients.Current status of anti-HBV chemotherapy.Evaluation by immune scanning electron microscopy of foscarnet treatment of cytomegalovirus infection in patients with renal transplants.Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.Susceptibility of different strains of pigeon herpesvirus to trisodium phosphonoformate.
P2860
Q27755387-21ABBA5C-68CE-4A91-8E5E-4845A3B7EE40Q28322607-D4E08664-171A-4769-8FA1-B10FF16A33E8Q28328446-431B6329-3DCD-4B95-9439-C1DE012F7D60Q28328858-B1A740AA-191D-4A0C-852D-854D30FD2F7DQ28360283-687B6976-37DD-4BB9-AF7C-7001B5088379Q28360556-198624E0-4E51-47B6-8C1F-FEBD5F9FE4B2Q28366251-2118B5B2-C621-483D-AAAB-4A7083387AFBQ28378983-AE73AC16-C99D-41A8-984A-25CFEE65C5F9Q30720731-58C7450F-03A1-4105-A106-45B8AE7722A6Q31493150-44FD2579-F55B-467F-9B4D-533DFCD13C98Q33930162-8C34C6B4-58BA-4CBC-9433-895DB8ACCE87Q35115200-55DAA185-B5D0-4B82-B5BF-A46FE2DA93FAQ35254452-C42D7AF0-559E-4F0C-B54A-F2AD441604A9Q35309077-189C21A8-7DEA-433A-821A-DC144B4CC031Q35569569-2C59C0EA-CD5F-44C8-983B-D5D705018CA8Q35758745-121DD4A2-0898-49E6-9697-7619607195F8Q35818856-FEF1D3EF-BA4B-4F0A-9B85-4B08F44383D5Q36070394-BCB16D17-4FAF-424D-A079-5ED15E23088FQ36268068-95B11D53-3060-4DDE-AFBB-227D68E84627Q36827232-F6F9BB35-B827-4024-9D50-DEE650E71DACQ36829444-D9CA0E86-93BE-4BD0-9E3B-D5A1DA9029E0Q36861742-E21CFB6B-0F29-45C6-B83A-A7E86893F1C9Q36897832-250F2405-B2A2-45EA-BC10-52B47A1BAEDBQ36914253-1AF2DF13-E650-4513-84EC-E0F445130B84Q37252268-06DC9945-0D1F-4FFA-B734-2B792C392F24Q39564490-90A77045-91AC-419E-8F63-1EFB61D1F38AQ39850580-646F4125-DF8D-4D85-B99C-BC68FA22368EQ40055204-904BFD8F-ADBD-4165-AA01-9A9AFF4BB14CQ40059070-6B1312D9-3DB9-4C88-8216-65EFBB949FB6Q40065708-C74B8EBB-62B5-429B-B602-97D21C74B76CQ40104485-C6F85CAE-9276-40BF-9073-40C72BB24B27Q40619479-20833B17-8821-4059-84F8-7DBA9180F436Q40620526-3920A433-B1EC-4AD5-AA2E-7971E9598C31Q43164438-FE003527-E14F-4D14-87D5-A5FE9D7BB02EQ43797919-8B1B84B6-38F1-4AB4-987A-C73533C6E262Q43850205-7179FAEB-2662-41CF-A9D8-32172F73E21DQ44662429-31273355-F065-4B50-8150-69C269CDDD40Q45838762-A4CF5957-4309-4E9B-9B8F-673E69DED323Q54539973-089CEB95-AFCF-4820-B907-5DFB589F0C7D
P2860
description
1978 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Science
@fr
artículu científicu espublizáu en 1978
@ast
im September 1978 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: September 1978)
@en
vedecký článok (publikovaný 1978/09/01)
@sk
vědecký článek publikovaný v roce 1978
@cs
wetenschappelijk artikel (gepubliceerd op 1978/09/01)
@nl
наукова стаття, опублікована у вересні 1978
@uk
name
Trisodium phosphonoformate, a new antiviral compound
@ast
Trisodium phosphonoformate, a new antiviral compound
@en
Trisodium phosphonoformate, a new antiviral compound
@nl
type
label
Trisodium phosphonoformate, a new antiviral compound
@ast
Trisodium phosphonoformate, a new antiviral compound
@en
Trisodium phosphonoformate, a new antiviral compound
@nl
prefLabel
Trisodium phosphonoformate, a new antiviral compound
@ast
Trisodium phosphonoformate, a new antiviral compound
@en
Trisodium phosphonoformate, a new antiviral compound
@nl
P2093
P356
P1433
P1476
Trisodium phosphonoformate, a new antiviral compound
@en
P2093
A Misiorny
B Eriksson
E Helgstrand
K Stenberg
N G Johansson
P304
P356
10.1126/SCIENCE.210500
P407
P577
1978-09-01T00:00:00Z